Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Medpeer Inc (6095)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
676.0 -11.0    -1.60%
02/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3921240002 
  • Volume: 147,200
  • Bid/Ask: 674.0 / 677.0
  • Day's Range: 672.0 - 693.0
Medpeer 676.0 -11.0 -1.60%

Medpeer Inc Company Profile

 
Get an in-depth profile of Medpeer Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustrySoftware & IT Services
SectorTechnology
Employees

611

Equity Type

ORD

MedPeer,Inc. offers services for doctors and pharmacists in Japan. The company develops various medical sites, such as MedPeer, a knowledge management tool where physician members can obtain various information centered on the collective knowledge of physicians; Yakubato, a medical institution based pharmacy reservation service; kakari, a family pharmacy support service; first call, a cloud-based health management service; Tonoel, a web service that allows health insurance union representatives, business office representatives, and industrial health staff to carry out tasks related to specific health guidance; kakari for Clinic, a family clinic support service; MedPeer Career, a physician career change/part-time job information site; Yakumed, a community site for pharmacists; Yakuchie for career and skill development of pharmacists; and Clinic Support, a physician practice and management support service. It also provides pharmaceutical companies with advertising space for ethical drugs and other products; research contracts, such as questionnaire surveys of doctors through the Internet from pharmaceutical companies, as well as dispatches contract MRs to pharmaceutical companies; DX services to medical institutions, including clinics and pharmacies that support operational efficiency at medical institutions and medical sites from chronic stages to home medical care; lifestyle guidance services face-to-face or online by a registered dietitian at the request of the health insurance association; online medical consultation, online industrial physician, stress check, and health checkup management services; and self-care services for general consumers, including pedometers and meal records. The company was incorporated in 2004 and is based in Tokyo, Japan.

Contact Information

Address 1-13-1 Tsukiji 9th floor
Ginza Shochiku Square Chuo-ku Tokyo, 104-0061
Japan
Phone 81 3 4405 4905
Fax -

Top Executives

Name Age Since Title
Yo Iwami 49 2004 President, CEO & Representative Director
Masayuki Shimura 66 2022 Independent Outside Director
Hiroyasu Sato 50 2012 External Auditor
Toshio Hirabayashi 43 2020 Director
Makoto Haruta 55 - Management Advisor
Mayuko Seto 55 2022 Independent Outside Director
Shunichi Sueyoshi 66 2017 Full Time Auditor
Takashi Hayama 77 2012 External Auditor
Naoki Goto 36 2023 Executive VP & Director
Masatoshi Kawana 71 2019 Independent Outside Director
Yoshihiko Tembo 49 2020 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

6095 Comments

Write your thoughts about Medpeer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email